Alnylam Pharmaceuticals | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Acadia Pharmaceuticals USD 19.29M 134.21M 2025-03
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Amgen USD 1.29B 1.02B 2025-03
Arrowhead Research USD -161412000 791K 2024-12
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Incyte USD 205.17M 96.34M 2025-03
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
Moderna USD -1050000000 196M 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 3.4B 193M 2024-12
PTC Therapeutics USD 970.22M 1.03B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Sanofi EUR 861M 2.77B 2024-12
Sarepta Therapeutics USD -300386000 462.07M 2025-03
Takeda JPY 66.94B 117.3B 2024-12
Tectonic Therapeutic USD -13991000 5.65M 2024-12
Ultragenyx Pharmaceutical USD -142939000 20.66M 2025-03
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12
Xencor USD -43183000 47.23M 2025-03



Alnylam Pharmaceuticals Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.